Topics
May/June 2010 | Oncology Feature
Von Hippel-Lindau Disease
A review of the physiopathlology, epidemiology, diagnosis, and treatment for this rare condition.
Hadas Newman, MD, and Paul T. Finger, MD
May 6, 2026
Neuvasq Highlights Data for Targeting Antibodies for Blood Retina Barrier Restoration at ARVO
Bayer Expands Ophthalmology Portfolio with Acquisition of Perfuse Therapeutics in Deal Worth Up to $2.45 Billion
May 5, 2026
Ametek Reichert Expands Tele-Optometry Capabilities with SightChek Integration into DigitalOptometrics Platform
Viridian Therapeutics Reports Positive Phase 3 Results for Thyroid Eye Disease Drug
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
